Total Funding
57
58
Total FundingSeries B raised
Growth Score 57 in past quarter
-1 pts
Heat Score 58 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
18421
MBrace Therapeutics is a privately held biopharmaceutical business.
- Wadih Arap: Founder
- Isan Chen: Chief Executive Officer and FounderPast Role: Aragon Pharmaceuticals, Chief Medical Officer
About the Company
MBrace Therapeutics is a privately held biopharmaceutical business dedicated to improving cancer patients' quality of life by developing antibody-drug conjugates (ADCs) against novel oncology targets.
Women Founded
